Skip to main content

The Tether™ - Vertebral Body Tethering System Post Approval Study

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about The Tether™ - Vertebral Body Tethering System Post Approval Study

A Dose Escalation/Expansion Study of Oral OP-1250 in Subjects With Advanced and/or Metastatic HR+, HER2- Breast Cancer

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about A Dose Escalation/Expansion Study of Oral OP-1250 in Subjects With Advanced and/or Metastatic HR+, HER2- Breast Cancer

A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Combination With Pembrolizumab Versus Pembrolizumab Alone for Patients With a Form of Head and Neck Cancer Positive for Human Papilloma Virus 16 and Expressing

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Combination With Pembrolizumab Versus Pembrolizumab Alone for Patients With a Form of Head and Neck Cancer Positive for Human Papilloma Virus 16 and Expressing

To Evaluate the Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis (LIMBER-313)

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about To Evaluate the Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis (LIMBER-313)

Optimizing Intralesional Triamcinolone Dosing for Hidradenitis Suppurativa

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Optimizing Intralesional Triamcinolone Dosing for Hidradenitis Suppurativa

Phase 2 Trial of MRTX849 Monotherapy and in Combination With Pembrolizumab for NSCLC With KRAS G12C Mutation KRYSTAL-7

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Phase 2 Trial of MRTX849 Monotherapy and in Combination With Pembrolizumab for NSCLC With KRAS G12C Mutation KRYSTAL-7

Efficacy and Safety of Odevixibat in Patients With Alagille Syndrome

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Efficacy and Safety of Odevixibat in Patients With Alagille Syndrome

Preoperative Melatonin to Decrease Analgesia Usage After Third Molar Surgery

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Preoperative Melatonin to Decrease Analgesia Usage After Third Molar Surgery

Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol

Study of Ociperlimab (BGB-A1217) in Combination With Tislelizumab in Advanced Solid Tumors

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Study of Ociperlimab (BGB-A1217) in Combination With Tislelizumab in Advanced Solid Tumors

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 200
  • Page 201
  • Page 202
  • Page 203
  • Page 204
  • Page 205
  • Page 206
  • Page 207
  • Page 208
  • …
  • Next page Next
  • Last page Last
Subscribe to